Alzheimer's drug fails clinical trial

The manufacturer Roche said that its new drug showed no clear benefit in slowing the progression of the disease

I'm Matt Jones with disappointing news that hopes for a treatment for Alzheimer's Disease have been dashed after an experimental drug failed a clinical trial. The manufacturer Roche said that its new drug showed no clear benefit in slowing the progression of the disease. The Alzheimer's Society said that there are still many other drugs in clinical trials and that they hope to find one that slows the disease or helps with symptoms. For more news stories, stay with us here on Care Radio.

More from Care News